Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells

Human Molecular Genetics

Volumn 21, Issue 18, 2012, Pages 4021-4029

  Motterle, Anna ^a   Pu, Xiangyuan ^a   Wood, Harriet ^a   Xiao, Qingzhong ^a   Gor, Shivani ^a   Liang ng, Fu ^a   Chan, Kenneth ^a   Cross, Frank ^b   Shohreh, Beski ^b   Poston, Robin N ^a   Tucker, Arthur T ^a,b   Caulfield, Mark J ^a   Ye, Shu ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ANRIL GENE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CHROMOSOME 9P; CORONARY ARTERY DISEASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A GENE; CYCLIN DEPENDENT KINASE INHIBITOR 2B GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ATHEROSCLEROSIS; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY CELL CULTURE; RNA, LONG UNTRANSLATED;

EID: 84865738718     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds224     Document Type: Article

References (36)

1. Samani, N.J., Erdmann, J., Hall, A.S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R.J., Meitinger, T., Braund, P., Wichmann, H.E. et al. (2007) Genomewide association analysis of coronary artery disease. N. Engl J. Med., 357, 443-453.
2. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A. et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science, 316, 1491-1493.
3. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R., Hinds, D.A., Pennacchio, L.A., Tybjaerg-Hansen, A., Folsom, A.R. et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science, 316, 1488-1491.
4. Kathiresan, S., Voight, B.F., Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P.M., Anand, S., Engert, J.C., Samani, N.J., Schunkert, H. et al. (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet., 41, 334-341.
5. Broadbent, H.M., Peden, J.F., Lorkowski, S., Goel, A., Ongen, H., Green, F., Clarke, R., Collins, R., Franzosi, M.G., Tognoni, G. et al. (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum. Mol. Genet., 17, 806-814.
6. Schunkert, H., Gotz, A., Braund, P., McGinnis, R., Tregouet, D.A., Mangino, M., Linsel-Nitschke, P., Cambien, F., Hengstenberg, C., Stark, K. et al. (2008) Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation, 117, 1675-1684.
7. Dandona, S., Stewart, A.F., Chen, L., Williams, K., So, D., O'Brien, E., Glover, C., Lemay, M., Assogba, O., Vo, L. et al. (2010) Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J. Am. Coll. Cardiol., 56, 479-486.
8. Patel, R.S., Su, S., Neeland, I.J., Ahuja, A., Veledar, E., Zhao, J., Helgadottir, A., Holm, H., Gulcher, J.R., Stefansson, K. et al. (2010) The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur. Heart J., 31, 3017-3023.
9. Helgadottir, A., Thorleifsson, G., Magnusson, K.P., Gretarsdottir, S., Steinthorsdottir, V., Manolescu, A., Jones, G.T., Rinkel, G.J., Blankensteijn, J.D., Ronkainen, A. et al. (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet., 40, 217-224.
10. Bilguvar, K., Yasuno, K., Niemela, M., Ruigrok, Y.M., von Und Zu, F.M., van Duijn, C.M., van den Berg, L.H., Mane, S., Mason, C.E., Choi, M. et al. (2008) Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat. Genet., 40, 1472-1477.
11. Yasuno, K., Bilguvar, K., Bijlenga, P., Low, S.K., Krischek, B., Auburger, G., Simon, M., Krex, D., Arlier, Z., Nayak, N. et al. (2010) Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat. Genet., 42, 420-425.
12. Ye, S., Willeit, J., Kronenberg, F., Xu, Q. and Kiechl, S. (2008) Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J. Am. Coll. Cardiol., 52, 378-384.
13. Anderson, C.D., Biffi, A., Rost, N.S., Cortellini, L., Furie, K.L. and Rosand, J. (2010) Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke, 41, 1123-1131.
14. Cluett, C., McDermott, M.M., Guralnik, J., Ferrucci, L., Bandinelli, S., Miljkovic, I., Zmuda, J.M., Li, R., Tranah, G., Harris, T. et al. (2009) The 9p21 myocardial infarction risk allele increases risk of peripheral artery disease in older people. Circ. Cardiovasc. Genet., 2, 347-353.
15. Angelakopoulou, A., Shah, T., Sofat, R., Shah, S., Berry, D.J., Cooper, J., Palmen, J., Tzoulaki, I., Wong, A., Jefferis, B.J. et al. (2012) Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration. Eur. Heart J., 33, 393-407.
16. Gil, J. and Peters, G. (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol., 7, 667-677.
17. Jarinova, O., Stewart, A.F., Roberts, R., Wells, G., Lau, P., Naing, T., Buerki, C., McLean, B.W., Cook, R.C., Parker, J.S. and McPherson, R. (2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler. Thromb. Vasc. Biol., 29, 1671-1677.
18. Burd, C.E., Jeck, W.R., Liu, Y., Sanoff, H.K., Wang, Z. and Sharpless, N.E. (2010) Expression of linear and novel circular forms of an INK4/ ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet., 6, e1001233.
19. Visel, A., Zhu, Y., May, D., Afzal, V., Gong, E., Attanasio, C., Blow, M.J., Cohen, J.C., Rubin, E.M. and Pennacchio, L.A. (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature, 464, 409-412.
20. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
21. Liu, Y., Sanoff, H.K., Cho, H., Burd, C.E., Torrice, C., Mohlke, K.L., Ibrahim, J.G., Thomas, N.E. and Sharpless, N.E. (2009) INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS ONE., 4, e5027.
22. Holdt, L.M., Beutner, F., Scholz, M., Gielen, S., Gabel, G., Bergert, H., Schuler, G., Thiery, J. and Teupser, D. (2010) ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler. Thromb. Vasc. Biol., 30, 620-627.
23. Cunnington, M.S., Santibanez, K.M., Mayosi, B.M., Burn, J. and Keavney, B. (2010) Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet., 6, e1000899.
24. Yap, K.L., Li, S., Munoz-Cabello, A.M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M.J. and Zhou, M.M. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell, 38, 662-674.
25. Folkersen, L., Kyriakou, T., Goel, A., Peden, J., Malarstig, A., Paulsson-Berne, G., Hamsten, A., Hugh, W., Franco-Cereceda, A., Gabrielsen, A. and Eriksson, P. (2009) Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS ONE., 4, e7677.
26. Iaquinta, P.J. and Lees, J.A. (2007) Life and death decisions by the E2F transcription factors. Curr. Opin. Cell Biol., 19, 649-657.
27. Polager, S. and Ginsberg, D. (2009) p53 and E2f: partners in life and death. Nat. Rev. Cancer, 9, 738-748.
28. Holdt, L.M., Sass, K., Gabel, G., Bergert, H., Thiery, J. and Teupser, D. (2011) Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis, 214, 264-270.
29. Gizard, F., Amant, C., Barbier, O., Bellosta, S., Robillard, R., Percevault, F., Sevestre, H., Krimpenfort, P., Corsini, A., Rochette, J. et al. (2005) PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a. J. Clin. Invest., 115, 3228-3238.
30. Gizard, F., Nomiyama, T., Zhao, Y., Findeisen, H.M., Heywood, E.B., Jones, K.L., Staels, B. and Bruemmer, D. (2008) The PPARalpha/ p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation. Circ. Res., 103, 1155-1163.
31. Segev, A., Nili, N., Qiang, B., Osherov, A.B., Giordano, F.J., Jaffe, R., Gauldie, J., Sparkes, J.D., Fraser, A.R., Ladouceur-Wodzak, M. et al. (2011) Inhibition of intimal hyperplasia after stenting by over-expression of p15: a member of the INK4 family of cyclin-dependent kinase inhibitors. J. Mol. Cell. Cardiol., 50, 417-425.
32. Zeller, T., Wild, P., Szymczak, S., Rotival, M., Schillert, A., Castagne, R., Maouche, S., Germain, M., Lackner, K., Rossmann, H. et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE., 5, e10693.
33. Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J.R., Insull, W. Jr, Rosenfeld, M.E., Schaffer, S.A., Schwartz, C.J., Wagner, W.D. and Wissler, R.W. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 89, 2462-2478.
34. Stary, H.C., Chandler, A.B., Dinsmore, R.E., Fuster, V., Glagov, S., Insull, W. Jr, Rosenfeld, M.E., Schwartz, C.J., Wagner, W.D. and Wissler, R.W. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 92, 1355-1374.
35. Libby, P. (1995) Molecular bases of the acute coronary syndromes. Circulation, 91, 2844-2850.
36. Reilly, M.P., Li, M., He, J., Ferguson, J.F., Stylianou, I.M., Mehta, N.N., Burnett, M.S., Devaney, J.M., Knouff, C.W., Thompson, J.R. et al. (2011) Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet, 377, 383-392.